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Background. To unravel the strategy by which Brucella abortus establishes chronic infections, we explored its early interaction
with innate immunity. Methodology/Principal Findings. Brucella did not induce proinflammatory responses as
demonstrated by the absence of leukocyte recruitment, humoral or cellular blood changes in mice. Brucella hampered
neutrophil (PMN) function and PMN depletion did not influence the course of infection. Brucella barely induced
proinflammatory cytokines and consumed complement, and was strongly resistant to bactericidal peptides, PMN extracts
and serum. Brucella LPS (BrLPS), NH-polysaccharides, cyclic glucans, outer membrane fragments or disrupted bacterial cells
displayed low biological activity in mice and cells. The lack of proinflammatory responses was not due to conspicuous
inhibitory mechanisms mediated by the invading Brucella or its products. When activated 24 h post-infection macrophages did
not kill Brucella, indicating that the replication niche was not fusiogenic with lysosomes. Brucella intracellular replication did
not interrupt the cell cycle or caused cytotoxicity in WT, TLR4 and TLR2 knockout cells. TNF-a-induction was TLR4- and TLR2-
dependent for live but not for killed B. abortus. However, intracellular replication in TLR4, TLR2 and TLR4/2 knockout cells was
not altered and the infection course and anti-Brucella immunity development upon BrLPS injection was unaffected in TLR4
mutant mice. Conclusion/Significance.We propose that Brucella has developed a stealth strategy through PAMPs reduction,
modification and hiding, ensuring by this manner low stimulatory activity and toxicity for cells. This strategy allows Brucella to
reach its replication niche before activation of antimicrobial mechanisms by adaptive immunity. This model is consistent with
clinical profiles observed in humans and natural hosts at the onset of infection and could be valid for those intracellular
pathogens phylogenetically related to Brucella that also cause long lasting infections.
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INTRODUCTION
Pathogenic bacteria use a variety of virulence factors that endow
them with the ability to overcome the immune system. Adhesins,
enzymes and toxins acting on host tissues, cells and free molecules
enable pathogens to breach host barriers and thwart defenses. In
most cases, however, the aggression is quickly sensed by innate
immune defenses that both act immediately and bolster the
adaptive immune response. Innate immunity detects minute
amounts of components bearing the so-called pathogen-associated
molecular patterns (PAMPs) as well as some products of host
damage [1]. The subsequent proinflammatory responses are
manifestations of the innate immunity and usual landmarks of
infection and septic syndromes. However, there is increasing
evidence that some pathogens display altered PAMPs in key
molecules, suggesting that to escape detection by innate immunity
is a survival strategy. One of the best examples of a structure with
altered PAMPs is the lipopolysaccharide (LPS) of Brucella (BrLPS),
an intracellular parasite of worldwide importance [2]. BrLPS bears
a non-canonical lipid A and, although it signals through toll-like
receptor (TLR) 4 [3], it is active only at very high concentrations
[4,5]. Moreover, BrLPS confers a highly resistant phenotype to
cationic bactericidal peptides and makes Brucella a poor activator
of the complement system [4,6]. Accordingly, we have suggested
that evading innate immunity is decisive for Brucella parasitism
[5,7]. Yet, there are conflicting reports on the role of TLR4 and
TLR2 in the immunity against live Brucella [8–12]. Although the
course of experimental brucellosis seems unaltered in TLR2
knockout (KO) mice [8,11,12], the receptor was shown to be
involved in the detection of heat-killed (HK) Brucella abortus [13].
Furthermore, some authors reported that Brucella lipoproteins
(BLPs) are potent triggers of proinflammatory cytokines through
TLR2, and proposed that B. abortus stimulates the innate immune
system and induces cytokine-mediated inflammation by this
mechanism [14]. Similarly, other authors have reported that
Brucella replicates to a higher extend in TLR4 KO mice than in the
WT [8,12], while others do not notice significant differences of
Brucella replication in these mice [9–11].
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These discrepancies are not trivial. At the onset of the infection,
brucellosis courses without significant endotoxicity signs or
significant blood changes [15], an unusual fact that calls for an
experimentally supported explanation. Moreover, Brucella lacks
classical virulence factors [16], although it possesses a type IV
secretion system VirB and periplasmic cyclic b-1,2-glucans that
enable the pathogen to reach its final replicating niche in the
endoplasmic reticulum [17,18]. In addition, BvrR/BvrS, a two
component sensory and regulatory system essential for Brucella
virulence, controls the outer membrane (OM) composition and
possibly aspects of the pathogen metabolism [19,20]. Since
activated macrophages successfully deal with intracellular Brucella
[21,22] it may be that prevention of early host cell activation is
a prerequisite for b-glucans, VirB and other factors to become
effective. To test this hypothesis, we have investigated the
proinflammatory responses induced by B. abortus in the murine
model in comparison with Salmonella typhimurium. We show here
that B. abortus behaves in fact as a furtive pathogen that
circumvents proinflammatory responses and propose that this
strategy does not rely on inhibitory mechanisms but rather on the
negligible activity of those molecules that bear marked PAMPs in
other bacteria. The data presented are consistent with clinical
profiles at the onset of brucellosis and argue that this model could
be valid for those intracellular pathogens phylogenetically related
to Brucella that also cause long lasting infections.
RESULTS
B. abortus infected mice do not show symptoms of
sepsis
As reported before [23,24], S. typhimurium induced symptoms of
septic shock in mice that started 2 h after intraperitoneal injection of
105 CFU and were initially characterized by piloerection, decrease
in feeding and water consumption and general malaise. At later
times, signs progressed to severe wasting and cachectia, with death
before 5 days. Pathological and histopathological examination of
the lungs demonstrated alveolar edema, hemorrhage, extensive air
space damage and PMN infiltration (not shown). None of these
symptoms were observed in mice injected intraperitoneally with
live- or HK-B. abortus in doses ranging from 104 to 107 CFU doses.
However, bacteria were isolated from blood as early as 1 h of
infection and bacteremia persisted for at least 48 h. Spleen cellular
profiles and weights between B. abortus-infected with 105 to 107
colony forming units (CFU) and PBS-injected mice did not differ
significantly in the first 48 h post-inoculation. Peritoneum and
spleen of B. abortus infected mice (104–105 CFU) had close to one log
increase in CFU at 24h of infection. Infection doses of 56109 to 1010
CFU of B. abortus did not induce the classical endotoxic shock profile
observed with Salmonella, although these bacterial quantities were
lethal for 50–60% of the mice after 48 h.
B. abortus infected mice do not demonstrate acute
coagulopathy disorders
Two critical events during strong proinflammatory responses are
platelet aggregation and synthesis of acute response proteins such as
fibrinogen [25]. Plasmin generation and the subsequent degradation
of fibrin are also linked to proinflammatory responses and PMN
activation [26]. Whereas S. typhimurium induced statistically signifi-
cant thrombocytopenia already 24 h of infection, for B. abortus this
was observed only after 48 h and at a less markedly level (Figure 1
A). Likewise, S. typhimurium- but not B. abortus-infected mice showed
increased fibrinogen synthesis (Figure 1 B) and generation of high
levels of plasmin activity (Figure 1 C).
B. abortus infection does not induce leukocytosis or
recruitment of PMN
Gram negative bacterial infections commonly generate leukocy-
tosis and PMN recruitment at early times. Thus, we explored the
leukocyte blood changes and PMN recruitment in mice infected
with B. abortus or S. typhimurium. As expected, the latter bacteria
induced noticeable blood neutrophilia (Figure 2 A) and a signifi-
cant recruitment of PMN and monocytes in the peritoneum
(Figure 2 B and C) and in the air pouch model in mice (Figure 2
D). In some cases, S. typhimurium also caused neutrophilia at early
stages followed by severe blood leucopenia starting at 10 h post-
inoculation (not shown). B. abortus did not induce significant
leukocyte blood changes or recruitment of PMN, monocytes or
lymphocytes in the peritoneum of mice, and only a mild
recruitment of PMN was observed in air pouches.
PMN do not play a significant role in the clearance
of B. abortus in vivo
The role of PMN during Brucella infections has not been critically
examined. We studied this aspect of innate immunity using mice
chronically depleted of PMN by treatment with monoclonal
antibody RB6. Bacterial counts were carried out 3 days of
infection for S. typhimurium and 7 and 14 days for B. abortus, times
at which these bacteria attain significant numbers in the spleen
[11]. Consistent with previous reports, S. typhimurium replicated to
a larger extent in PMN depleted than in control mice [27]. In
contrast, B. abortus spleen CFU were similar in both groups after 7
or 14 days of infection (Figure 3 A). Since Brucella colonization of
spleen and other organs takes place during the first hours [28,29]
and the phagocytosis of PMN starts immediately after bacterial
invasion [30], these results show that the role of PMN in the
Figure 1. B. abortus does not induce augmented levels of fibrinogen,
fibrin-breakdown products or important platelet aggregation. Balb/c
mice (6 mice per group) were intraperitoneally injected with 106 CFU of
B. abortus 2308, 105 CFU S. typhimurium (6 mice per group) or 0.1 ml of
PBS (10 mice per group) and blood was collected from the retro-orbital
sinus and the blood from the various individuals subjected to analysis.
(A) The number of platelets was determined by flow cytometry. (B) The
levels of fibrinogen were determined in plasma. (C) The levels of fibrin
D-dimers in the plasma from infected and PBS injected control mice
were determined by agglutination of sensitized beads, after 48 h pos-
infection. Minimum positive cut-off (0.5 mg/ml) is represented with
a dashed line. Values of p,0.05 (*), p,0.005 (**) and p,0.0005 (***) are
indicated.
doi:10.1371/journal.pone.0000631.g001
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control of B. abortus is not significant, even once adaptive immunity
has developed.
PMN are not significantly active against B. abortus
ex vivo
It has been shown that virulent smooth brucellae hamper PMN
degranulation and are more resistant than LPS defective strains to
the killing action of PMN [31]. These properties, however, have
not been weighed against those of other facultative intracellular
gram negative bacteria. As expected [32], S. typhimurium stimulated
the respiratory burst (Figure 3 B), did not prevent PMN
degranulation (Figure 3 C) and was readily killed by these rat
cells (Figure 3 D). Under the same conditions, B. abortus induced
only a mild respiratory burst and a modest PMN degranulation
(Figure 3 B and C), two facts more evident at rates of infection of
8–10 B. abortus per PMN than at lower rates. The inhibitory effect
on degranulation lasted for up to 6 h post inoculation, a time when
all control and S. typhimurium infected rat PMN were degranulated.
Consistent with these observations, B. abortus was resistant to the
killing action of human and rat PMN (Figure 3 D).
B. abortus barely consumes complement and is
resistant to bactericidal molecules
Since complement activation and intracellular killing by micro-
bicidal molecules are events linked to proinflammatory mechanisms,
we compared the ability of B. abortus and S. typhimurium to consume
complement and their resistance to cationic peptides, PMN extracts
and normal serum. In contrast to S. typhimurium, B. abortus barely
displayed anticomplementary activity (Figure 4 A) and it was
considerable more resistant to the action of bactericidal cationic
peptide p-EM2, PMN-extracts and normal serum (Figure 4 B).
B. abortus infection induces minimal levels of
cytokines
Although it has been shown that live- and killed-Brucella induce
proinflammatory cytokines [8,11,13,21,33,34], the in vivo levels
and kinetics at early times have not been contrasted with those in
other infections. As expected, S. typhimurium induced a fast increase
in TNF-a, IL-1b and IL-6 levels that reached their maximum 2, 4
and 10 h post inoculation, respectively, and then decreased rapidly
(Figure 5 upper panel). Concomitantly, the levels of anti-
inflammatory IL-10 increased steadily up to at least 24 h of
infection. In contrast, the levels of these four cytokines were
comparatively insignificant after infection with B. abortus (Figure 5
upper panel). This markedly lower response was not linked to an
active interference by the live bacteria because inocula of HK-B.
abortus did not increase the cytokine levels (Figure 5 upper and
center panels). It is important to note that, in this and subsequent
experiments, HK-bacteria were not washed after killing because it
is known that heat disrupts Brucella cell envelopes and exposes
large amounts of BrLPS, BLPs, peptidoglycan, DNA and other
molecules [35] as a rule recognized by innate immunity. Although
both HK- and live-B. abortus displayed effects much lower and
widely different from those of S. typhimurium, they did not induce
identical activities, as demonstrated when the scale of the graphs
are modified to portray more resolution (Figure 5 center panel).
Live-B. abortus stimulated TNF-a, IL-1b and IL-6 biphasic
Figure 2. B. abortus does not induce leukocytosis or significant recruitment of PMN. Leukocyte counts were determined in the peritoneal fluids,
heparinized blood or in the air pouch of Balb/c mice intraperitoneally injected with 106 CFU B. abortus 2308, 105 CFU S. typhimurium or 0.1 ml PBS. (A)
Blood PMN were counted in 8 mice/group, during different periods. (B) Leukocyte values in the peritoneum were determined from fluids of 5 mice/
group, in time. The inserted graph indicates the values of peritoneal lymphocytes and monocytes at 24 h. (C) The peritoneal PMN recruited were
determined as in ‘‘(B)’’. (D) PMN in air pouches were determined from the fluids of 5 mice/group, during 4 periods. PMN average numbers of PBS
injected mice in each period (blue-dashed line) and the ranges of normal maximum upper and lower limits are depicted in each graphic (gray bar).
doi:10.1371/journal.pone.0000631.g002
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responses with steady increases after 8 h post inoculation, whereas
HK-B. abortus induced a response with a different kinetics and
lower amounts of cytokines after 10 h. Only when mice were
infected with a very high dose of Brucella (56109 CFU), the levels of
cytokines approached those induced by Salmonella (Figure 5 lower
panel). Similarly, 56109 of HK-B. abortus induced a modest
increase in cytokines (Figure 5 lower panel) and mild signs of
endotoxemia, but not lethality, probably due to the lower levels of
Figure 4. B. abortus does not consume complement and is resistant to PMN extracts, cationic peptides and serum. (A) Packed bacteria were
incubated with normal rabbit serum and the remaining hemolytic activity of complement in serum measured in a complement fixation indicator
system: higher hemolytic activity corresponds to less complement consumption by the bacteria. (B) Bactericidal activity was determined by
incubating 46105 CFU of bacteria with 5 mM of cationic peptide pEM-2 or 5 mg/ml of PMN-extract in 0.2 ml PBS-1 % peptone, for 20 and 30 min.
Complement bactericidal activity was estimated on 105 CFU/ml bacterial suspensions dispensed in wells of microtiter plates (45 ml/well) containing
fresh normal human serum (45 ml/well). Bactericidal action was estimated as the percentage of CFU with respect to controls without pEM-2, PMN
extract or decomplemented inactivated serum, respectively. Values of p,0.005 (**) and p,0.0005 (***) are indicated.
doi:10.1371/journal.pone.0000631.g004
Figure 3. PMN are not required for innate control of B. abortus infection. (A) Balb/c mice were given repeated injections of the anti-RB6 antibody
to deplete PMN. Untreated or PBS injected mice were used as controls. Two days later, all mice were intraperitoneally infected with 106 CFU of B.
abortus 2308 or 105 S. typhimurium. During the infection, mice were treated with anti-RB6 antibody every two days, for a maximum of 7 days. Spleen
bacterial counts were determined 3 days of infection for Salmonella and 7 and 14 days of infection for B. abortus. (B) In situ respiratory burst was
estimated as the rate of Brucella or Salmonella infected rat PMN containing NBT positive granules at proportion of 1 or 10 bacteria/cell. (C)
Degranulation of infected rat PMN (564 bacteria/cell) at two cell densities/well was estimated by microscopic examination (406 upper panel and
206 lower panel) at 3 h and expressed as the proportion of degranulated cells versus intact PMN in 5 fields. Standard error was less than 10% in all
cases. (D) The rate of B. abortus or S. typhimurium survival in human and rat PMN was tested at 564 bacteria/cell, at two post infection times. Values
of p,0.005 (**) and p,0.0005 (***) are indicated.
doi:10.1371/journal.pone.0000631.g003
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TNF-a generated. Moreover, the cytokine profiles were different
from those induced by live-bacteria. Since we were able to
overcome the low cytokine response by using very large inocula,
our results demonstrated that the low levels of proinflammatory
cytokines induced by B. abortus infection were not connected to
inhibitory mechanisms exerted by the infecting bacteria.
B. abortus molecules putatively bearing PAMPs do
not inhibit cytokine responses and are low
activators
To test whether the Brucella molecules that putatively bear PAMPs
hampered activation or, on the other hand, were just poorly
detected, we performed two experiments. First, we challenged
mice and macrophages with high concentrations of a collection of
B. abortus fractions containing those molecules (Table 1), and
measured the TNF-a levels (Figure 6). Second, we injected
Escherichia coli LPS (EcLPS) alone or after the respective B. abortus
fractions and compared the TNF-a levels with those measured in
the first experiment. All B. abortus fractions induced very low levels
of TNF-a in mice after 2 or 8 hours, even at high concentrations
(50 mg/mouse) but none of them inhibited the generation of this
cytokine after activation with EcLPS. Similarly, only high concen-
trations of the B. abortus preparations (50 mg/ml) generated TNF-
a in macrophages and no preparation inhibited a subsequent
activation by EcLPS. Concentrations lower that 10 mg/mouse or
10 mg/well of the B. abortus fractions induced very low or
undetectable levels of cytokines. On the contrary, 0.05–5 mg/well
of EcLPS induced significant levels of TNF-a (not shown).
Similarly, very low to undetectable levels of the inhibitory cytokine
IL-10 were observed in macrophages treated with the B. abortus
fractions. This was in contrast to EcLPS, which induced significant
amounts of this cytokine after 24 h (not shown). None of the
Brucella fractions was toxic for mice or macrophages. These
experiments demonstrate that, in addition of being low activators,
the Brucella molecules that putatively bear PAMPs (Table 1) do not
inhibit the generation of TNF-a in vivo or in vitro.
Replicating intracellular B. abortus are protected
from macrophage activation
It has been proposed that activated macrophages are the primary
source for B. abortus elimination in the infected host [29,33].
However, our in vivo observations suggested that macrophage
activation could be both delayed with respect to the onset of B.
abortus infection and insufficient to lead to an effective control of
the pathogen. To study this hypothesis, we first compared the
brucellacidal activity of non-activated macrophages and macro-
Figure 5. B. abortus infections induce a blunted cytokine response. The levels of IL-10, IL-1b, IL-6 and TNF-a were determined in the sera of Balb/c
mice (6 per group) intraperitoneally infected with 106 CFU of B. abortus 2308, 105 CFU of S. typhimurium or injected with 106 CFU of HK-B. abortus
(upper and center panels). Alternatively, mice were infected with 56109 CFU of B. abortus 2308, or injected with 56109 of HK-B. abortus. Untreated or
intraperitoneally injected with 0.1 ml PBS control groups displayed negligible quantities of cytokines (not shown). Notice that the scales of the
graphics between the upper and center panels differ in at least one order of magnitude.
doi:10.1371/journal.pone.0000631.g005
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phages exogenously activated before or during infection. Macro-
phages were treated or not with EcLPS, then inoculated with B.
abortus and CFU determined 2 h later. The results showed that
macrophages pretreated with EcLPS were considerably more
brucellacidal than naive macrophages (Figure 7 A), and that
treatment did not increase the proportion of cell death as compare
to the infected controls without EcLPS treatment (not shown).
Then, naı¨ve macrophages were infected with B. abortus, incubated
for 24 h until intracellular replication started. At this time, they
were treated with EcLPS or left untreated. As shown in Figure 7 B,
Brucella replication proceeded unaltered in the macrophages
treated with EcLPS at 24 h of infection. In all these experiments,
macrophage activation was not endogenously inhibited by the
intracellular bacteria, as demonstrated by the production of similar
TNF-a levels in infected and non-infected macrophages upon
EcLPS stimulation (Figure 7 C). Altogether, these results
Figure 6. B. abortus PAMP-bearing molecules and extracts do not block the generation of TNF-a in vivo and in vitro. (A) Balb/c mice (10 per
group) were intraperitoneally. injected with 50 mg/0.05ml PBS of each of the different B. abortus preparations described in Table 1, or with 0.05 ml
PBS alone. Then, halve of the mice from each group were intraperitoneally injected with 5 mg/0.05 ml PBS of EcLPS, and the other halve with 0.05 PBS
alone, and TNF-a levels determined in sera at 2 and 8 hours after the last injection. (B) RAW264.7 macrophages were treated with 50 mg/well with
each of the various preparations described in Table 1. After 30 min, halve of the cultures were challenged with 5 mg/well of EcLPS and the levels of
TNF-a determined from culture supernatants at 4 and 24 hours. (C) Omp10, Omp16 and Omp19 lipoproteins in Brucella OMF revealed by Western
blots with the respective monoclonal antibodies. Value of p,0.05 (*) is indicated.
doi:10.1371/journal.pone.0000631.g006
Table 1. Characteristics of the PAMP-bearing preparations used in this study for stimulating mice and macrophages.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Preparation Description
BrLPS B. abortus LPS possesses an O-amphypatic chain homopolymer composed of N-formyl-perosamine subunits, a core oligosaccharide devoid of negative
charges, and a lipid A backbone of two subunits of diaminoglucose substituted with long chain (up to 30 C atoms) of hydroxylated and unsaturated
fatty acids. The preparation contains 85% LPS, 11% NH, 1.5% protein and 2.5 % of other components. B. abortus LPS mutants are attenuated.
[3,4,20,56,79].
EcLPS E. coli LPS is a classic endotoxic preparation composed of hydrophylic O chain, highly negative charged core oligosaccharide and a canonical lipid A
composed of two subunits of glucosamine substituted with short chain (,16 C atoms) hydroxylated and saturated fatty acids. This preparation
contains of 87% LPS, 2% protein and 11% other components [3].
Gluc/NH Preparation NH2 composed of 65% of cyclic beta-1,2-glucan substituted with anionic succinyl residues, 30% NH, and 5% of other components. B.
abortus mutants in cyclic beta-1,2-glucan or devoid of O-chain derived polysaccharides, including NH are attenuated [79].
OMF Outer membrane fragments composed of 42% BrLPS, 26% NH, 18% proteins, and 10% phospholipids and ornithine-containing lipids. Proteins include
60 periplasmic proteins and 25 OM proteins, from which 10 are BLPs, including Omp10, Omp16 and Omp19. B. abortus mutants in several Omps, and
BLPs are attenuated [19,35,58].
Cyto This preparation is 96% protein from which 65% are cytoplasmic, 25% periplasmic, 5% membrane associated and 1% membrane. A significant
proportion of the cytoplasmic and periplasmic proteins are devoted to folding, sorting, degradation and transport functions. BLPs, LPS, NH or beta-1, 2
cyclic glucans were not detected in this preparation [35,79].
HK-B. abortus Heat killed B. abortus was prepared by boiling B. abortus 2308 in pyrogen-free PBS for 10 minutes without further washing the bacterial debris. This
preparation includes exposed peptidoglycan, nucleic acids, and mixtures of membrane components.
doi:10.1371/journal.pone.0000631.t001..
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established that previously activated macrophages display higher
brucellacidal activity than naı¨ve ones. Moreover, they demonstrate
that B. abortus infected macrophages are not refractory to further
activation and also that such an activation does not lead to the
elimination of replicating Brucella.
TLRs barely respond to high levels of Brucella
molecules putatively bearing PAMPs and do not
influence bacterial replication
The lack of macrophage activation induced by Brucella could be
explained by an insufficient triggering of PAMP receptors. To test
this, we measured the production of TNF-a by bone marrow (BM)
macrophages of WT, TLR4-/- TLR2-/- and TLR4/TLR2-/-
mice upon stimulation with bacterial products, live- and HK- B.
abortus (Figure 8). The levels of TNF-a induced by the Brucella OM
fragments (OMF) or BrLPS at 50 mg/ml were lower than that
induced by EcLPS at 0.1 mg/ml (Figure 8 A). In spite of this, the
recognition of purified BrLPS and OMF depended on TLR
(Figure 8 A). Recognition of OMF, a material that contains high
quantities of BrLPS and several BLPs (Table 1 and Figure 6 C), did
not depend on TLR2; however, the absence of both, TLR4 and
TLR2, abolished the response. In a second set of experiments, we
compared the TNF-a induction in macrophages inoculated with
live- and unwashed HK- B. abortus. TLR KOs but not WT
macrophages generated differential and lower levels of TNF-
a when infected than when inoculated with unwashed HK-B.
abortus (Figure 8 B), demonstrating in vitro dependence on TLR4
and TLR2 by live- but not by HK-bacteria. As expected, the
TNF-a levels induced by Brucella were at least 3 times lower than
those generated in WT macrophages stimulated with EcLPS
(Figure 8 panels A and B). These results prompted us to investigate
the multiplication of Brucella in macrophages deficient for these
receptors. In agreement with our previous observations of in vivo
infections in TLR KO mice [11], the replication of B. abortus in
TLR4-/-, TLR2-/- and TLR4/TLR2-/- macrophages did not
differ from those in WT (Figure 8 C). Therefore, whereas TNF-
a secretion in cultured macrophages infected with B. abortus seems
to depend somewhat on TLR2 and TLR4, signaling by these
receptors does not affect the intracellular replication of this
pathogen.
B. abortus intracellular replication has no cytotoxic
effects
Salmonella is cytotoxic for BM macrophages in a TLR2 and/or
TLR4-independent manner [36]. In contrast, Brucella replicates
extensively within macrophages and inhibit apoptosis in human
monocytes [18,37]. Therefore, we determined the survival of WT
and different TLR KO macrophages infected with B. abortus. The
viability of uninfected macrophages steadily decreased during
7 days of culture and there were no significant differences in the
death rate among the various types of cells, demonstrating that the
TLR KO macrophages do not have a generalized survival
deficiency (Figure 9 A). The viability of TLR4/TLR2-/-
macrophages infected with B. abortus also decreased, although
not at the same rate as the uninfected controls (Figure 9 B). On the
contrary, no decrease in the viability was detected in B. abortus-
infected WT, TLR4 -/- and TLR2 -/- macrophages. Similar
results were obtained with HK-Brucella, suggesting that steady
replication within macrophages was not necessary to promote
survival (Figure 9 C). Since the IL-1b and IL-18 receptors signal
through the MyD88 molecule like TLRs, we tested if IL-1b and
IL-18 signaling contributed to macrophage survival after B. abortus
infection. As shown in Figure 9 D, the decrease in viability was
also suppressed in Brucella infected IL-1b/IL-18-/- macrophages.
Figure 7. Macrophages activated before infection are significantly more brucellacidal than macrophages activated after infection. (A) Naı¨ve or
activated RAW264.7 macrophages with EcLPS 0.5 mg/well 15 h prior to infection, were infected with B. abortus 2308 at 1065 bacteria/cell and the
microbicidal function estimated after 2 h post inoculation. Under these conditions no significant cytotoxicity was recorded in these phagocytic cells.
(B) Naı¨ve macrophages were infected at rate of 1065 bacteria/cell and bacteria replication estimated; after 24 h, half of the infected macrophages
were activated with 0.5 mg/well EcLPS (black squares) and the rest of the cells treated with PBS (white squares) and bacterial replication followed until
48 h post inoculation. Immunofluorescence of replicating Brucella at 24 h of infection (arrows) is shown in the inserted figure. (C) TNF-a measured in
the supernatants of non-infected EcLPS 0.5 mg/well activated macrophages (black circles), non-activated B. abortus infected cells (white triangles), or
EcLPS activated cells after 24 h of B. abortus infection (red circles). Value of p,0.0005 (***) is indicated.
doi:10.1371/journal.pone.0000631.g007
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Figure 8. Brucella intracellular replication is TLR4 and TLR2 independent but TNF-a production is TLR4 and TLR2 dependent. (A) BM
macrophages from WT, TLR4-/-, TLR2-/- and TLR4/TLR2-/- C57Bl/6 mice were inoculated with 50 mg/well of B. abortus OMF, 50 mg/well of BrLPS or
0.1 mg/well of EcLPS (A) and TNF-a measured after 24 h. (B) BM macrophages from WT, TLR4-/-. TLR2-/- and TLR4/TLR2-/- C57Bl/6 mice were infected
with B. abortus 2308 (infection rate of 1065 bacteria/cell) or treated with 10 HK-B. abortus/cell and TNF-a measured after 48 h. (C) BM macrophages
were infected as in ‘‘(B)’’ and bacterial replication determined as the number of CFU during different periods. Values of p,0.05 (*), p,0.005 (**) and
p,0.0005 (***) are indicated.
doi:10.1371/journal.pone.0000631.g008
Figure 9. Brucella is not cytotoxic for macrophages and HeLa cells. (A) Survival rate of uninfected WT, TLR4-/-, TLR2-/- and TLR4/TLR2-/- BM
macrophages from C57Bl/6 mice was followed using MTT assay for seven days. (B) Survival of macrophages infected with B. abortus S19 at MOI of 50.
(C) Survival of macrophages treated with 50 mg/ml of HK-B. abortus S19. (D) Survival of WT and IL-1b/IL-18-/- macrophages infected with B. abortus
S19 (MOI 50). (E) Untreated (panel 1) and CNF treated (panels 2, 3 and 4) HeLa cells were infected with B. abortus 2308 at a MOI of 500 and incubated
for 48 h. Untreated cells (panel 1) were incubated with BrdU. All cells were processed for immunofluorescence [39] using anti-BrLPS antibodies (green
in panel 1 and red in panels 2, 3 and 4) or antibodies against BrdU epitope (red in panel 1). CNF treatment inhibits the cytokinesis while not affecting
karyokinesis resulting in the generation heavily infected cells during the mitotic cycle (panel 2, cell in anaphase), binucleated cells (panel 3) or
multinucleated cells (panel 4). Values of p,0.005 (**) and p,0.0005 (***) are indicated.
doi:10.1371/journal.pone.0000631.g009
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These results indicate that B. abortus, in addition to its lack of
toxicity for BM macrophages, this bacterium was able to promote
the survival of these cells, even in the absence of signaling by
relevant TLR or cytokine receptors.
Epithelial cells are decisive host cells for the establishment of
brucellosis [38]. In order to determine if extensive replication of
Brucella induced cell death through toxic effects or apoptosis, we
infected naı¨ve and E. coli cytotoxic necrotizing factor (CNF)-
treated (in order to avoid cytokinesis) HeLa cells and monitored
the cell cycle. As expected [39], extensively infected HeLa cells
were able to synthesize DNA, condense chromosomes and
perform several cycles of nuclear division, demonstrating that
even large amounts of intracellular Brucella not induce toxicity in
these cells (Figure 9 E).
B. abortus replication and immunity in vivo are not
dependent on TLR4
There are coincident results showing that TLR2 is not required for
the efficient clearance of either virulent or attenuated B. abortus in
vivo [8,11]. On the other hand, it has been described [8] that
virulent B. abortus increased up to one log in the spleens of TLR4-
deficient C3H/HeJ mice as compared to the WT counterparts.
However, a hampered response of C3H/HeJ mice to B. abortus was
not noticed in previous works [9,10] or more recently in C57BL/6
TLR4-/- mice [11]. Since the use of an attenuated Brucella strain
more easily reveals a permissive effect connected with macrophage
dysfunction [40], we first reexamined the in vivo role of TLR4
using C3H/HeJ mice and the cognate WT strain infected with
attenuated B. abortus S19. We found that B. abortus S19 replicated
and persisted similarly in C3H/HeJ as in WT mice (Figure 10 A).
Assays performed with virulent B. abortus 2308 also failed to reveal
differences in the course of the infection in these mice (not shown).
We also examined the role of TLR4 by immunizing TLR4-/- KO
and WT mice with BrLPS and challenging them with B. abortus.
Consistent with the antibody responses induced by B. abortus LPS
in TLR4 deficient mice [11], no differences in protection levels
between TLR4-/- and WT mice were observed (Figure 10 B).
These results reinforce the proposal that clearance and de-
velopment of efficient immunity to B. abortus is TLR4-independent
[11], despite of the fact that BrLPS is TLR4 dependent in vitro,
although at much higher concentrations than other kind of LPSs
[3].
DISCUSSION
We have evaluated the degree and profiles of the early
proinflammatory responses induced by B. abortus and several
PAMP-bearing molecules in comparison with those evoked by the
intracellular pathogen S. typhimurium. This comparative approach
allowed us to estimate the level at which Brucella is able to activate
innate immunity at the onset of the infection. It is important to
note that the data obtained accurately correlate with the absence
of endotoxicity signs, the rarity of leucocytosis and neutrophilia
and the almost total absence of coagulopathies in patients with
brucellosis [15,41]. Therefore, our observations are complemen-
tary to a significant body of clinical data. The picture that emerges
from this study is as follows.
After invading, the brucellae come in contact with humoral
mediators and are readily ingested by PMN and macrophages
[30,41], and probably by dendritic cells [42]. At this stage, Brucella
performs several tasks to avoid immediate destruction: first, it
circumvents strong activation of the innate immune system;
second, the bacterium withstands the direct action of complement
and other bactericidal substances; third, it resists and evades the
action of professional phagocytes, such as PMN and macrophages;
finally, Brucella maintains the host cells alive in order to establish
long lasting infections.
The first task is accomplished through a negligible induction of
proactive plasma inducers of inflammation, insignificant levels of
complement fixation and delayed and low levels of cytokines and
chemokines, as demonstrated here and in other works [3,11,43].
These effects should be connected to the low recruitment of
leukocytes at early times and the weak brucellacidal action of
PMN. Despite these low-activating properties of Brucella, it was
striking that the course of infection was unaffected in mice
depleted of granulocytes because PMN kill these bacteria at
significant higher rates than macrophages [18,31]. The brucella-
cidal activity of PMN is promoted by opsonization with normal
sera [44] but it seems that the negligible complement binding
displayed by B. abortus (Figure 4 A) which is related to the poor
complement binding of its LPS [4] would be a limiting factor. It is
noteworthy that the lack of role of PMN parallels that of NK cells
in the sense that they are not crucial for the control of B. abortus at
early times of infection [21], at least in the murine model. A
possible general consequence of these observations is that PMN,
the foremost cells of innate immunity, may serve as carriers
Figure 10. B. abortus replicates in naı¨ve and BrLPS vaccinated TLR4 deficient mice (A) TLR4 deficient mutant C3H/HeJ and the WT counterpart
C3H/HeAu mice were infected with 106 CFU B. abortus S19 and the number of replicating bacteria counted from the spleen at different time periods
(5 mice per group). (B) WT and TLR4-/- C57Bl/6 mice were injected with PBS (5 mice per group) or intraperitoneally immunized with BrLPS (5 mice per
group) and after two weeks infected with 106 CFU B. abortus S19 and the number of replicating bacteria in the spleen of mice counted at 14 days of
infection.
doi:10.1371/journal.pone.0000631.g010
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spreading viable B. abortus in the body as proposed by Spink more
than 50 years ago [41].
At first glance, these results are in apparent disagreement with
previous studies that reported PMN infiltration in B. abortus
infected organs [29] and increased and reduced bacterial
replication in mice depleted of TNF-a or IL-10, respectively
[45,46]. A close examination shows, however, that most of the
phenomena described in those studies correspond to late times,
once adaptive immunity has initiated or been established [47], and
that the cellular infiltrates in the organs are predominately
mononuclear [29]. It is also significant that the ability of
macrophages to control intracellular B. abortus is affected by IL-
10 only at very high concentrations [45], and that IL-6 and TNF-
a have no major effect [33], in contrast to INF-c which is the key
cytokine in the control of brucellosis [21]. Therefore, our
observations at the onset of B. abortus infection are not in
contradiction with those made once the adaptive immunity has
developed.
Activated macrophages control Brucella efficiently, an effect
noted even before the term ‘‘activated macrophage’’ was coined
[22]. Since then, it has remained an unsolved problem how Brucella
is able to persist in the infected host despite macrophage activation
and a patently active and long lasting adaptive immunity.
Furthermore, it has been noted that elimination of NADPH
oxidase or nitric oxide synthase activity in mice does not affect the
recovery of B. abortus in these animals [48], suggesting that these
and possibly other crucial functions of activated cells are not
relevant in brucellosis. Therefore, a very significant observation
was that, once established in naı¨ve macrophages, subsequent
activation did not lead to Brucella clearance. It has been also shown
that virulent B. abortus induces less macrophage activation than
attenuated strains, as estimated by in situ esterase staining of
mononuclear cells in vivo [22].
Live Brucella does not release cytotoxic substances [16,49] and it
seems to prolong the survival of macrophages independently of
TLR4, TLR2, IL-1b or IL-18. These properties enable Brucella to
replicate without generating obvious cell damage, a characteristic
that may be essential for establishing long lasting chronic
infections. Some dependence, however, was observed when both
TLRs were absent, suggesting that signaling by at least one of
these receptors is required to prologue survival. Similarly, Brucella
infected epithelial cells are able to cycle and consequently remain
as reservoirs for the bacteria in vivo. Dendritic cells have been
shown to sustain Brucella replication [42] and thus may participate
in immunity or serve as reservoirs, a hypothesis that deserves
experimental testing. Other cells such as lymphocytes, which are
crucial for mounting an efficient adaptive immunity at later times
[21], may not play a significant role at the onset of the infection. It
seems, therefore, that a crucial step in Brucella pathogenesis is to
sneak to its replicating niche without cell activation or cell cycle
interruption. Once there, macrophages are unable to destroy
intracellular replicating Brucella, not because they are refractory to
activation, but rather because their niche becomes unsuitable for
fusion with lysosomes. Finally, the apoptosis inhibition [37] may
be also linked to the absence of caspases mediating proinflamma-
tory activation.
It is not known whether Brucella containing vacuoles fail to fuse
with lysosomes because they are part of the endoplasmic
reticulum, because these vacuoles are modified in such a way
that they do not have the appropriate docking molecules, or both.
In this connection, the lack of significant involvement of TLR4
and TLR2 in the initial steps of B. abortus infection is remarkable.
It has been demonstrated that, whereas early involvement of
TLR4 and TLR2 promotes an inducible mode of phagocytosis
characterized by a rapid fusion with lysosomes, their absence
allows constitutive and slower maturation of the phagocyted
particles [50]. Based on the biogenesis of B. abortus containing
vacuoles in macrophages [18], the slow and low modulation of
TLRs in B. abortus infected cells [11] and the unaltered replication
profiles displayed in TLR4, TLR2 and TLR4/2 KO phagocytes
(Figure 8 B), we propose that maturation of the Brucella containing
phagosome initially follows the constitutive pathway which is then
diverted by the activity of Brucella factors. Indeed, the b-1,2-
glucans and VirB system have been demonstrated to hamper
lysosomal fusion and redirect Brucella to its replicating niche, once
the bacterium has invaded and localized in early vacuoles [17,18].
The absence of a TLR4 effect on Brucella replication in
macrophages is in agreement with the results observed in the
C3H/HeJ mice, here and in other works [9,10,51], and with our
previous experiments in TLR4-/- mice [11], but in apparent
contradiction with others [8,12]. Although we do not know the
reasons for these discrepancies, there are several considerations
that can be made. First, the Brucella and mice strains used (e.g. B.
abortus versus B. melitensis; Brucella resistant versus sensitive mice) as
well as the bacterial doses and experimental settings, differ among
the various works. Second, the differences in CFU observed at
early times between TLR4 KO and WT mice, although
statistically demonstrable display low significance and it is
manifested at early times but not at later times [12], suggesting
low influence of this TLR in the course of Brucella infection. It is
also significant that TLR4-/-, TLR4/2-/- and C3H/HeJ mice
infected with Brucella or immunized with BrLPS generate strong
anti-LPS antibody responses [11,52], and that these antibodies
were protective in TLR4-/- mice (Figure 10), suggesting low
relevance of TLR4 for immunity against Brucella. These observa-
tions point out that TLR4, a conspicuous LPS cell receptor of the
innate immune system, is not important for mounting an efficient
and protective immune response against Brucella as it is the case in
other gram negative infections [53]. However, Myd88, which is
the adaptor molecule for several TLRs and interleukin receptors,
is clearly required for the control of Brucella replication in mice
[11,12], suggesting that some signaling through receptors that use
Myd88 is required to control brucellosis, mainly once adaptive
immunity has taken place.
The ability of Brucella to behave as a stealthy parasite seems to
be connected to physiological and structural features and not to
classical virulence factors specifically designed to foil the immune
system [16]. It is clear that early innate immunity detection failed
mostly because of both the absence or reduced number of
molecules with canonical PAMPs and the lack of cytotoxic
substances generated by B. abortus. Indeed, Brucella is devoid of
surface structures such as capsules, fimbriae and pili, structures
that are all conspicuous in many soil living Brucella relatives [54].
In addition, BrLPS poorly binds cationic bactericidal peptides
[6,55] and, although it induces TLR4-dependent cytokine
responses, its bioactivity is markedly lower than that of canonical
LPSs, as demonstrated here and in previous works [3–5,11,20].
These differences are largely accounted for by the relative
reduction of anionic groups in the core oligosaccharide, diami-
noglucose backbone and the presence of long and very long acyl
chains in amide and acyloxyacyl linkages in the lipid A [56]. These
features may also hamper its interaction with coupling molecules
such lipid binding proteins, CD14 and MD-2, as suggested
elsewhere [57].
In addition to LPS, there are other PAMP bearing molecules in
the gram-negative OM. Based on the analysis of the activity of B.
abortus BLPs purified from recombinant E. coli, it has been
proposed that they are key elements triggering proinflammatory
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responses [14]. In our work, the cytokine levels induced in vitro and
in vivo by live- and HK-Brucella as well as by OMF are far lower
than those induced by Salmonella. Since OMF contain significant
quantities of the three major B. abortus BLPs (Figure 6 C), our
results indicate that they are poor inducers of innate immunity, at
least in the context of the whole bacterium or in OMF. It has been
noted that triggering of TLR2 by lipopeptides and lipoproteins
depends dramatically on the type of fatty acids substituting these
molecules and to less extent on their amino acid composition [58].
Thus, one possible explanation for the differences between our
observations and those with cloned B. abortus BLPs is that the latter
carry the acylation pattern characteristic of E. coli. The chain
length of the bound fatty acids is larger in Brucella than in
Enterobacteriaceae [59] and, in an early study on the trypsin fragment
of a Brucella BLP, one of us reported that the fatty acids differed
considerably from those in the peptidoglycan-linked E. coli
lipoprotein [60]. Although structural studies are necessary for
a definite conclusion, the equivalent response of WT and TLR2-/-
as well as the lower response of TLR4-/- BM macrophages treated
with OMF support the hypothesis that Brucella BLPs display
a structure with reduced or altered PAMP. An additional factor
that could account for the differences between B. abortus and
Salmonella may lay in their BLP content. Proteomic studies have
identified 15 different BLPs in B. abortus OMF [61], a number that
contrasts with the more than 100 putative BLPs present in
Salmonella genomes [62]. Cell envelope ornithine-containing lipids
from several bacteria have also been shown to be strong inducers
of cytokines and prostaglandins [63]. However, the structures of
Brucella ornithine-containing lipids (also present in the OMF) differ
from those of Achromobacter, Bordetella and Flavobacterium in at least
the type of fatty acids [59,63]. Concerning flagella, although the
brucellae are non-motile, this structure can be expressed on the
surface of these bacteria [64]. However, Brucella flagellin, the
putative cognate PAMP molecule for TLR5, displays an amino
acid sequence not recognized by this receptor [65].
The cytokine profiles and TLR dependence observed in vivo or
in cultured cells with live- and killed-bacteria or their isolated
PAMPs display a good correlation in many pathogens, including
Salmonella [66,67]. This was not the case with B. abortus. In contrast
to OMF (devoid of DNA and peptidoglycan), unwashed HK-B.
abortus induced cytokine profiles that were not dependent on TLR4
and TLR2. It is likely that TLR9 and NOD-like receptors which
are the cognate receptors for Brucella DNA [12] and may be for its
canonical peptidoglycan [60], respectively, are the responsible
receptors for inducing these TLR4 and TLR2 independent
responses in vitro. It may be also that TLR9 [12] and eventually
NOD-like receptors functioning intracellularly, are the relevant
TLRs for controlling Brucella infection through specialized
dendritic cells acting in concert with other cells for generating
IFN-c [12]. However, this still does not explain the negligible levels
of proinflammatory cytokines in vivo, mainly when PAMPs such as
DNA and peptidoglycan are readily accessible in HK-Brucella.
Why did HK-B. abortus induce a low level of cytokines in vivo and
why did the live bacteria show TLR4 and TLR2 dependence for
cytokine release in macrophages and no dependence on these
TLRs during replication in vivo [11] or in vitro (Figure 8 C)? This is
surprising because a number of B. abortus are killed by
macrophages during the first hours of infection [18,68] without
significant activation of the infected cells, as demonstrated here.
All these results indicate that the availability of Brucella PAMPs
within infected cells or elsewhere in the host is not straightforward
and that those interpretations based on the interaction between
Brucella molecules putatively bearing PAMPs and cell receptors
require careful attention.
It is tempting to speculate that the stealthy strategy of Brucella
corresponds to an evolutionary path that has been followed by
several pathogenic a-Proteobacteria by taking advantage of a com-
mon structural heritage. For instance, Bartonella, another in-
tracellular parasite inducing long lasting infections in mammals,
shares with Brucella the chemical and biological characteristics of
its lipid A, core oligosaccharide, major fatty acids, low number of
BLPs, putative enzymes to built ornithine-lipids, and flagella not
recognized by TLR5 [62,65,69,70]. The brucellae, and probably
other pathogenic a-Proteobacteria have developed furtive character-
istics by eradicating, modifying or hiding otherwise moderately
active PAMP-bearing molecules, to the point that practically not
recognized by the corresponding receptors. In the case of Brucella,
this is complemented by the maintenance of b-1,2-glucans, type
IV secretion apparatus, BrLPS and sensing and regulatory systems
that allow to reach a safe intracellular niche before an effective
immune response is developed [17–21].
MATERIALS AND METHODS
Bacterial strains, fractions and biological reagents
Salmonella enterica sv. Typhimurium strain SL1344, virulent B.
abortus 2308 and attenuated B. abortus S19 were grown as described
[54,71]. Description and characterization of BrLPS, EcLPS, OMF,
b-1,2-glucans, native hapten polysaccharide (NH), cytoplasmic
fractions and HK-B. abortus are described in Table 1. The
characteristics of bactericidal cationic peptide p-EM2, PMN-
extracts, CNF and anti-Brucella and anti-S. typhimurium antibodies,
have been described previously [6,39,55,72]. Enzyme linked
immunosorbent assay (ELISA) kits for cytokine determination were
from BD Biosciences (San Diego, CA). Monoclonal antibody RB6-
8C5 against murine granulocytes was a gift from Ba¨rbel Raupach,
MPIIB, Berlin, Germany. Monoclonal antibodies against Omp10,
Omp16 and Omp19 were a gift from Axel Cloeckaert, Unite´
BioAgresseurs, Sante´ et Environnement, INRA, France.
Experimental animals
The characteristics, source and maintenance of Balb/c, C3H/
HeJ, C3H/HeAu, C57BL/6 and the KO counterparts TLR4-/-,
TLR2-/-, TLR4/TLR2-/- and IL-1b/IL-18-/- mice have been
described previously [11,52]. Wistar rats were maintained in the
animal facility of the Veterinary School of the National University,
Costa Rica. All animals were handled and sacrificed according to
the guidelines of the ‘‘Comite´ Institucional para el Cuido y Uso de
los Animales of the Universidad de Costa Rica’’, and in agreement
with the corresponding law ‘‘Ley de Bienestar de los animals
Nu74510 of Costa Rica. Mice were infected by the intraperitoneal
route with 0.1 ml of bacteria in pyrogen-free sterile PBS.
Generation of neutropenic mice
Balb/c mice were intraperitoneally injected with 100 mg of RB6-
8C5 antibody, 36 h before infection. Then mice were infected
with 106 B. abortus or 105 S. typhimurium. Controls were injected
with sterile PBS. Thereafter, mice were injected with 100 mg every
two days (one injection for S. typhimurium and 3 injections for B.
abortus) until sacrificed. One single intraperitoneal injection of
100 mg of RB6 antibody resulted in PMN depletion for at least
3 days. Under these circumstances the blood of mice bled from the
tail, did not demonstrate granulocytes during the course of
experiments, as judged by Giemsa-Wright staining of the smears.
Neither circulating nor resident populations of macrophages,
lymphocytes or other resident cells were affected by this treatment.
On day 3, mice infected with S. typhimurium and the respective
controls were sacrificed. B. abortus infected mice and the respective
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controls were sacrificed on days 7 and 14. Bacterial colonization
was determined in spleens of mice collected at the indicated times,
then weighed and homogenized in 1 ml sterile PBS. Serial
dilutions were plated on Luria agar plates for S. typhimurium and
trypticase soy agar for B. abortus and CFU per g of spleen
calculated.
Macrophage, HeLa and PMN cell cultures
Murine RAW264.7 (ATCC TIB-71), HeLa (ATCC CCL-2) cells
and BM-derived macrophages from C57BL/6 and the KO
counterparts TLR4-/-, TLR2-/-, and TLR4/TLR2-/- mice were
prepared, cultured and infected following previous protocols
[11,18,39]. Fresh preparations or PMN were obtained from air
pouches of Wistar rats (150-200 g) as described by Fukura and
Tsurufuji [73]. Human PMN were purified from heparinized
blood as described elsewhere [74]. The human cell preparations
and rat exudates were composed from 95-99 % PMN per
nucleated cells. Erythrocyte contamination was less that 5% of the
packed cells. PMN preparations were maintained at 4uC in PBS,
and used within the first h after extraction.
Cell infections
Infections of BM and RAW264.7 macrophages and HeLa cells
were carried out as described [11,36,39]. Briefly, plates containing
56105 RAW264.7 or 26105 BM macrophages were inoculated at
the ratio of 200 or 50 B. abortus per cell, respectively. For S.
typhimurium, a rate of infection of 2 bacteria per cell was used. At
these multiplicities, similar numbers of B. abortus and S. typhimurium
infected cultured macrophages as determined by immunoflures-
cence. PMN infections were performed as follows: suspensions of
106 rat PMN in 0.5 ml of PBS supplemented with 0.2 mM CaCl2,
5 mM MgCl2 and 10% of human serum, were infected with B.
abortus or S. typhimurium at multiplicity of infection (MOI) ranging
from 5 to 100 bacteria per cell, and the mixture incubated for
15 minutes at 37uC under mild rotation. PMN/bacteria mixtures
were centrifuged at 2000 g to remove non-ingested bacteria. Then,
infected PMN were suspended in supplemented PBS in the
presence of 10 mg/ml of gentamicin for 30 minutes at room
temperature to kill extracellular bacteria. Tubes were centrifuged
at 2500 g for 5 minutes and cell pellets resuspended in 400 ml of
supplemented PBS without gentamicine and incubated at 37uC
under mild rotation for additional 45 and 90 minutes. The
proportion of infected cells and the number of bacteria per cell was
directly determined by direct immunofluorescence using fluores-
cein isotiocyanate-IgG anti-Brucella LPS as described elsewhere
[39]. Under these experimental conditions, from 70–85 % of the
macrophages were infected at initial times, with 1–3 B. abortus per
macrophage, while close to 100 % of the PMN were infected with
1–10 bacteria per cell. For macrophages, plates were washed with
PBS and cells lysed by adding 0.1% Triton X-100 (Sigma) for
10 minutes. For PMN, samples were centrifuged and the infected
cells resuspended 50 ml of PBS and then lysed by adding 200 ml of
0.1% Triton X-100. For determination the number of B. abortus,
aliquots were plated in tryptic soy agar; for S. typhimurium CFU
determination, LB agar plates were used.
Cell functions and immunofluorescence
In situ respiratory burst of infected and non-infected rat PMN was
estimated by the reduction of nitroblue tetrazolium (NBT, from
Sigma) to dark-blue insoluble formazan granules trapped within
vacuoles as described [74]. The number of non-infected rat PMN
with positive NBT granules was considered as background and
subtracted from the total number of infected cells presenting
positive granules. Degranulation of rat PMN was estimated by
counting in the number of intact cells remaining in a 406 field by
phase contrast microscopy. For this, infected and non-infected
PMN were incubated at 37uC in supplemented PBS without
antibiotics or serum, under mild rotation during different time
periods. Macrophage activation was performed on infected and
non-infected cells by adding 0.5 mg/ml of EcLPS in the well.
Medium samples from infected and uninfected cells were taken at
different times and frozen at 220uC until used for TNF-
a determination. Procedures for immunofluorescence microscopy
have been described elsewhere [39]. For B. abortus detection, the
fluorescein isotiocyanate-conjugated anti-Brucella antibody was
directly used. For S. typhimurium detection, cells were first incubated
with mouse anti-S. typhimurium antibody and then with TRITC-
conjugated anti-mouse antibody. Counts of cell associated bacteria
were performed in at least 100 infected cells.
Toxicity of replicating Brucella in cells was estimated in BM
macrophages and HeLa cells as previously described [39,75].
Briefly, 3-(4,5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bro-
mide (MTT, from Sigma Chemical Co., St. Louis, Mo) was added
to monolayers of BM macrophages at each time point. Then, cells
were incubated for 2 h at 37u C, 7% CO2, lysed and the rate of
survival estimated by colorant release at the optical density of
570 nm. Two-fold dilutions of cells were freshly seeded and used
to make a standard curve. DNA synthesis was estimated by
immunofluorescence in 48 h B. abortus infected HeLa cells, using
10 mg/ml bromodeoxyuridine (BrdU; Sigma) in combination with
monoclonal anti-BrdU (Clone BU-33; Sigma). Nuclei were
contrasted with Hoescht stain (Sigma). Replication of Brucella in
dividing HeLa cells treated with CNF was recorded by
immunofluorescence after 48 h.
Determination of fibrinogen, fibrin dimers, and
cytokines
For fibrinogen, fibrin dimers were determined from the plasma of
infected mice by the clotting method of Clauss [76], and the semi-
quantitative D-Di testH latex agglutination assay (Diagnostica Stago),
respectively. The levels of IL-10, IL-1b, IL-6 and TNF-a were
estimated by ELISA according to the manufacturer’s specifications,
in the culture supernatants of macrophages or in the sera of Balb/c
mice intraperitoneally infected with S. typhimurium, B. abortus, or
intraperitoneally inoculated with fresh killed HK-B. abortus.
Platelets and leukocyte counts
Balb/c mice from 18 and 20 g were intraperitoneally injected with
105 CFU of B. abortus , S. typhimurium or 0.1 ml pyrogen-free sterile
PBS, and blood from tail collected in heparinized glass capillary
tubes at different time points. Alternatively, 5 ml of ice cold PBS
were injected in the peritoneal cavity of killed the mice, and the
fluids collected with a syringe (from 3.8 to 4.5 ml) from exposed
peritoneal cavity [77]. Then fluids were centrifuged and the
peritoneal cells resuspended in 0.2 ml of PBS and counted. Four
estimating the recruitment of leukocytes sterile in air pouches
Balb/c 25–30 g mice, the procedure of Garcı´a-Ramallo et al. [78]
was followed. Briefly, anesthetized animals were subcutaneous
injected with 2.5 ml of sterile air under the dorsal skin on day 0 and
day 3; three days after, 106 of B. abortus or 105S. typhimurium in 1 ml
PBS were injected into the air pouch cavities. Animals were
sacrificed at different time points and fluids from the pouches
harvested and cells counted. Total leukocytes, PMN, red blood
cells and platelets were counted in each sample using an ABX
Micros 60 analyzer (ABX Hematologie, France) and confirmed in
blood smears. The number of cells recruited in the peritoneum or
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in air pouches was corrected according to the volume of fluid
collected in each animal.
Determination of complement consumption and
bactericidal action of molecules
Complement consumption estimated as the reduction of the
hemolytic activity of serum complement incubated with live
bacteria, was determined as described elsewhere [77]. Bactericidal
action mediated by PMN-extracts and cationic peptide pEM-2
was performed as previously described [55,72]. For the estimation
of complement bactericidal activity the protocol performed
previously was followed [20].
Statistics
Student’s t test for was used for determining the statistical
significance in the different assays. For bacterial colonization
experiments, the Mann-Whitney test was performed accordingly
(http://faculty.vassar.edu/lowry/utest.html).
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